Durvalumab After Concurrent Chemoradiotherapy in Elderly Patients With Unresectable Stage III Non–Small–Cell Lung Cancer (PACIFIC)
Mark A. Socinski, Mustafa Özgüroğlu, Augusto Villegas, Davey B. Daniel, David Vicente, Shuji Murakami, Rina Hui, Jhanelle E. Gray, Keunchil Park, Mark Vincent, Helen Mann, Michael Newton, Phillip A. Dennis, Scott Antonia
Topics & Concepts
DurvalumabMedicineChemoradiotherapyStage (stratigraphy)Lung cancerOncologyInternal medicineCancerImmunotherapyNivolumabPaleontologyBiologyCancer Immunotherapy and BiomarkersLung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations